January 31, 2019
Janssen Pharmaceutical’s prostate cancer drug apalutamide, also known as Erleada overseas, sailed through a key health ministry panel on January 30, opening the way for its approval as early as March. The Pharmaceutical Affairs and Food Sanitation Council’s (PAFSC) Second...read more